- Presentations
- 3
- Markets
- 1
Vitrakvi is a brand of Larotrectinib marketed by Bayer HealthCare Pharmaceuticals, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Larotrectinib
- Brand owner
- Bayer HealthCare Pharmaceuticals
- Registered in
- United States
- Strengths and forms
- 100 mg capsule, 25 mg capsule, 20 mg/mL oral concentrate
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Vitrakvi 100 mg capsuleOral Cold chain | Bayer HealthCare Pharmaceuticals | US FDA | Available on request |
| Vitrakvi 25 mg capsuleOral Cold chain | Bayer HealthCare Pharmaceuticals | US FDA | Available on request |
| Vitrakvi 20 mg/mL oral concentrateOropharyngeal Cold chain | Bayer HealthCare Pharmaceuticals | US FDA | Available on request |
Equivalent brands
Other brands of Larotrectinib.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Vitrakvi
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.